Does the dexamethasone suppression test reliably discriminate between psychotic and nonpsychotic major depression?: An exploratory analysis of potential confounds

Journal of Nervous and Mental Disease

Volumn 197, Issue 6, 2009, Pages 395-400

  Gaudiano, Brandon A ^a,b   Epstein Lubow, Gary ^a,b   Miller, Ivan W ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

Author keywords

Anxiety; Depression; Dexamethasone suppression test; Hypothalamic pituitary adrenal axis; Psychosis

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; BIOLOGICAL MARKER; CORTICOSTEROID; CORTICOTROPIN; DIAGNOSTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DEXAMETHASONE SUPPRESSION TEST; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; RELIABILITY; ANXIETY DISORDER; BLOOD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOSIS; PSYCHOTHERAPY; QUESTIONNAIRE;

ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 67649403403     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3181a775cf     Document Type: Article

References (64)

1. APA (2004) Diagnostic and Statistical Manual of Mental Disorder (4th ed). Washington (DC): American Psychiatric Association.
2. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd ed). Washington (DC): American Psychiatric Association.
3. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry. 4:561-571.
4. Beck AT, Steer RA, Garbin RA (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 8:77-100.
5. Bland JM, Altman DG (2000) Statistics notes: The odds ratio. BMJ. 320:1468.
6. Brown RP, Stoll PM, Stokes PE, Frances A, Sweeney J, Kocsis JH, Mann JJ (1988) Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia and other illness variables. Psychiatry Res. 23:167-178.
7. Buchanan JP, Dixon DR, Thyer BA (1997) A preliminary evaluation of treatment outcomes at a veterans' hospital's inpatient psychiatry unit. J Clin Psychol. 53:853-858.
8. Burke HM, Davis MC, Otte C, Mohr DC (2005) Depression and cortisol responses to psychological stress: A meta-analysis. Psychoneuroendocrinology. 30:846-856.
9. Calloway SP, Dolan RJ, Fonagy P, De Souza VF, Wakeling A (1984) Endocrine changes and clinical profiles in depression: I. The dexamethasone suppression test. Psychol Med. 14:749-758.
10. Carroll BJ (1985) Dexamethasone suppression test: A review of contemporary confusion. J Clin Psychiatry. 46:13-24.
11. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Arch Gen Psychiatry. 38:15-22.
12. Charney DS, Nelson JC (1981) Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes. Am J Psychiatry. 138:328 -333.
13. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences (2nd ed). Hillsdale (NJ): Lawrence Erlbaum Associates.
14. Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G (2007) Hormonal differences between psychotic and non-psychotic melancholic depression. J Affect Disord. 100:65-73.
15. Derogatis LR (1994) SCL-90-R: Administration, Scoring and Procedures Manual. Minneapolis (MN): National Computer Systems, Inc.
16. Derogatis LR, Lipman RS, Covi L (1973) SCL-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull. 9:13-28.
17. Derogatis LR, Savitz KL (2000) The SCL-90-R and Brief Symptom Inventory (BSI) in primary care. In ME Maruish (Eds), Handbook of Psychological Assessment in Primary Care Settings (pp 297-334). Mahwah (NJ): Lawrence Erlbaum Associates.
18. Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP (2000) Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry. 24:207-225.
19. Ehlert U, Gaab J, Heinrichs M (2001) Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 57:141-52.
20. Farmer A, McGuffin P (1989) The classification of the depressions. Contemporary confusion revisited. Br J Psychiatry. 155:437- 443.
21. Fink M (2005) Should the dexamethasone suppression test be resurrected? Acta Psychiatr Scand. 112:245-249.
22. Fink M, Taylor MA (2007) Resurrecting melancholia. Acta Psychiatr Scand Suppl. 14-20.
23. Gaudiano BA, Beevers CG, Miller IW (2005) Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression. J Nerv Ment Dis. 193:625-628.
24. Gaudiano BA, Dalrymple KL, Zimmerman M (2009) Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic. Depress Anxiety. 26:54-64.
25. Gaudiano BA, Miller IW (2007) Dysfunctional cognitions in hospitalized patients with psychotic versus nonpsychotic major depression. Compr Psychiatry. 48:357-365.
26. Gaudiano BA, Young D, Chelminski I, Zimmerman M (2008) Depressive symptom profiles and severity patterns in outpatients with psychotic versus nonpsy-chotic major depression. Compr Psychiatry. 49:421-429.
27. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56-62.
28. Haynes SN, Lench HC (2003) Incremental validity of new clinical assessment measures. Psychol Assess. 15:456-466.
29. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB (2000) Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 284:592-597.
30. Keitner GI, Fruzzetti AE, Miller IW, Norman WH, Brown WA (1989) The effect of anticonvulsants on the dexamethasone suppression test. Can J Psychiatry. 34:441-443.
31. Keller J, Schatzberg AF, Maj M (2007) Current issues in the classification of psychotic major depression. Schizophr Bull. 33:877-885.
32. Kendell RE (1976) The classification of depressions: A review of contemporary confusion. Br J Psychiatry. 129:15-28.
33. Kocsis JH, Davis JM, Katz MM, Koslow SH, Stokes PE, Casper R, Redmond DE (1985) Depressive behavior and hyperactive adrenocortical function. Am J Psychiatry. 142:1291-1298.
34. Lattuada E, Serretti A, Cusin C, Gasperini M, Smeraldi E (1999) Symptomato-logic analysis of psychotic and non-psychotic depression. J Affect Disord. 54:183-187.
35. Mellsop GW, Hutton JD, Delahunt JW (1985) Dexamethasone suppression test as a simple measure of stress? Br Med J (Clin Res Ed). 290:1804-1806.
36. Meyers BS (2006) Psychotic depression. Psychiatric Ann. 36:7-9.
37. Meyers BS, Peasley-Miklus C, Flint AJ, Mulsant BH, Rothschild AJ (2006) Methodological issues in designing a randomized controlled trial for psychotic depression: The STOP-PD study. Psychiatric Ann. 36:57-64.
38. Miller I, Norman W, Bishop S (1985) The modified Hamilton Rating Scale for Depression. Psychiatry Res. 14:131-142.
39. Miller I, Norman W, Keitner G (1989) Cognitive-behavioral treatment of depressed inpatients: Six- and twelve-month follow-up. Am J Psychiatry. 146: 1274-1279.
40. Miller I, Norman W, Keitner G, Bishop S, Dow M (1988) Cognitive-behavioral treatment of depressed inpatients. Behav Ther. 19:673- 695.
41. Mossner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Muller N, Fallgatter AJ, Riederer P (2007) Consensus paper of the WFSBP Task Force on Biological Markers: Biological markers in depression. World J Biol Psychiatry. 8:141-174.
42. Mullen PE, Linsell CR, Parker D (1986) Influence of sleep disruption and calorie restriction on biological markers for depression. Lancet. 2:1051-1055.
43. Nelson JC, Davis JM (1997) DST studies in psychotic depression: A meta-analysis. Am J Psychiatry. 154:1497-1503.
44. Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC (1990) The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand. 81:120-125.
45. Parker G, Hadzi-Pavlovic D, Brodaty H, Austin MP, Mitchell P, Wilhelm K, Hickie I (1995) Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med. 25:825-832.
46. Robins L, Helzer J, Croughan J, Ratcliff K (1981) National Institute of Mental Health Diagnostic Interview Schedule. Arch Gen Psychiatry. 38:381-389.
47. Rosse RB, Deutsch LH, Deutsch SI (2000) Medical assessment and laboratory testing in psychiatry. In BJ Sadock, VA Sadock (Eds), Kaplan and Sadock's Comprehensive Textbook of Psychiatry (7th ed, Vol 1, pp 732-755). Philadelphia (PA): Lippincott Williams and Williams.
48. Rothschild AJ (2003) Challenges in the treatment of depression with psychotic features. Biol Psychiatry. 53:680-690.
49. Rothschild AJ (1996) Management of psychotic, treatment-resistant depression. Psychiatric Clin North Am. 19:237-252.
50. Rubin DB (1973) Matching to remove bias in observational studies. Biometrics. 29:159-183.
51. Schatzberg AF (2003) New approaches to managing psychotic depression. J Clin Psychiatry. 64(suppl 1):19-23.
52. Schatzberg AF, Rothschild AJ (1992) Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 149:733-745.
53. Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO (1983) The dexamethasone suppression test: Identification of subtypes of depression. Am J Psychiatry. 140:88 -91.
54. Sher L (2006) Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism and suicidal behavior. Scientific World Journal. 6:1398-1404.
55. Shorter E (2007) The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl. 5-13.
56. Stangl D, Pfohl B, Zimmerman M, Coryell W, Corenthal C (1986) The relationship between age and post-dexamethasone cortisol: A test of three hypotheses. J Affect Disord. 11:185-197.
57. Tiller JW, Biddle N, Maguire KP, Davies BM (1988) The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry. 23:261-270.
58. van Praag HM (2000) Nosologomania: A disorder of psychiatry. World J Biol Psychiatry. 1:151-158.
59. Verdoux H, van Os J (2002) Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res. 54:59-65.
60. Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, Nelson JC (2003) Psychotic depression and mortality. Am J Psychiatry. 160:574-576.
61. Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH (2006) The dex/CRH test-is it better than the DST? Psychoneuroendocrinology. 31:889-894.
62. Wetzler S, Marlowe DB (1993) The diagnosis and assessment of depression, mania and psychosis by self-report. J Pers Assess. 60:1-31.
63. Young EA, Abelson JL, Cameron OG (2004) Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 56:113-120.
64. Zimmerman M, Spitzer RL (1989) Melancholia: From DSM-III to DSM-III-R. Am J Psychiatry. 146:20-28.